- Home
- RVMD vs ABLLL Comparison
RVMD vs ABLLL Comparison
Compare RVMD & ABLLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVMD | ABLLL |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | 125 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | N/A |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RVMD | ABLLL |
|---|---|---|
| Price | $78.82 | $25.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $77.11 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | N/A |
| Earning Date | 11-05-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $714.50 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.17 | N/A |
| 52 Week High | $81.49 | N/A |
Technical Indicators
Market Signals| Indicator | RVMD | ABLLL |
|---|---|---|
| Relative Strength Index (RSI) | 73.68 | 58.84 |
| Support Level | $77.54 | $25.28 |
| Resistance Level | $81.49 | $25.43 |
| Average True Range (ATR) | 2.51 | 0.08 |
| MACD | -0.48 | 0.01 |
| Stochastic Oscillator | 75.46 | 79.51 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About ABLLL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.